Articles
-
Read ArticleNew Century Health to Support Florida Blue Medicare with Comprehensive Oncology Management Services
The company will leverage New Century Health’s oncology specialty management program to help ensure its more than 125,000 Medicare Advantage members receive high-quality cancer care.
-
Watch VideoKey Forces Impacting Cancer Care: An Interview with Dr. Vinay Prasad
New Century Health's John Davis recently sat down with Dr. Prasad, author of "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer," to discuss key forces impacting cancer care.
-
Read External ArticleOncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping
-
Read ArticleHow Real-World Evidence Can Transform High-Value Oncology Pathways
Our CMO Dr. Andrew Hertler explains how real world evidence may usher in the next generation of clinical oncology pathways.
-
Read ArticleHigh-Value Clinical Pathways Help Illinois Cancer Practice Reduce Drug Spend
Recent journal article details how NCH and Cancer Care Specialists of Illinois teamed up to slow growth in drug spend.
-
Read Press ReleaseNew Century Health Achieves NCQA Accreditation in Utilization Management
NCH also recertified by HITRUST® for patient privacy and data security protection.
-
Read ArticleNew Century Health Achieves NCQA Accreditation in Utilization Management
Specialty care management company also recertified by HITRUST® for patient privacy and data security protection.
-
Read ArticleDriving Culture Change in the Pursuit of Value: A Q&A with Cancer Care Specialists of Illinois
Dr. Mark Walshauser describes the impact of high-value oncology pathways and peer collaboration on his community practice.
-
Read External ArticleHow Clinical Pathways Are Growing
Increasing use of real-world evidence is one of the most exciting trends in pathway development, our CMO tells Journal of Clinical Pathways.
-
Read External ArticleClinical Pathways Slow Drug Spending in Community Oncology
Medscape delves into our work with a community oncology practice to implement high-value clinical pathways and engage providers
-
Watch VideoA Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology
Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and impact of COVID-19.
-
Read ArticleWill COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?
The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.
-
Read External ArticleNew Century Health Pathways Help Community Practice Reduce Drug Spending
Our chief medical officer, Dr. Andrew Hertler, speaks with Journal of Clinical Pathways about our approach to high-value cancer care.
-
Read Press ReleaseIllinois Practice Shows Empowering Oncologists Can Reduce Cancer Drug Spend
Cancer Care Specialists of Illinois reduced drug spend by 13.5% compared to peer practices by deploying our care pathway and physician collaboration protocols
-
Watch WebinarOn-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care
Watch this on-demand webinar to explore the future of cancer care in a post COVID-19 world.
-
Watch VideoThe Impact of COVID-19 on Oncology Practices and the Delivery of Cancer Care: Insights from our Scientific Advisory Board Roundtable
Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.
-
Read ArticleCancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks
Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.
-
Read ArticleCOVID-19 Resources for Providers and Health Plans
A compilation of infection prevention resources, regulatory updates and guidance for managing high-risk populations in this pandemic.
-
Read ArticleCreating a "Culture of Yes" in Prior Authorization
Prior authorization is a major source of frustration for providers and patients. Our CMO Dr. Andrew Hertler explains how a value-based approach can change that.
-
Read External ArticleThe Financial Burden of Breast Cancer
As more cancers are treated like chronic conditions, financial toxicity has become a greater problem, our CMO Dr. Andrew Hertler tells Next Avenue.
-
Loading More...
